Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male Volunteers
NCT02182076 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2014-07-18
Summary
Study to assess pharmacokinetics and the extend of absorption of a single dose of BIBF 1120 soft gelatine capsule with food effect (BA) in healthy subjects respectively.
Conditions
- Healthy
Interventions
- DRUG
-
BIBF 1120
150 mg of BIBF 1120 ES soft gelatine capsules
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-10-31
- Primary Completion
- 2005-11-30
More Related Trials
-
Bioavailability of BIBR 953 ZW Under Influence of Food in Healthy Subjects
NCT02170597 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male Volunteers
NCT02182154 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181
NCT02044406 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects
NCT03302078 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule in Healthy Japanese Male Subjects
NCT02171000 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects
NCT02227030 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Bioavailability Study of BIA 9-1067 25 mg Capsules
NCT02071823 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions
NCT01764945 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men
NCT03837964 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BI 44370 TA Drinking Solution or Tablets With and Without a High Fat Meal in Healthy Male and Female Volunteers
NCT02215746 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects
NCT02264197 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Increasing Repeated Doses of BIIF 1149 BS in Healthy Male Volunteers
NCT02203487 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Solution Formulation in Healthy Volunteers
NCT02182284 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female Subjects
NCT02183493 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood
NCT03871595 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers
NCT02161432 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 515 BS or Pravastatin in Hyperlipemic Healthy Male Subjects
NCT02266485 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems
NCT05661344 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions
NCT01897597 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers
NCT02268604 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin
NCT02170844 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood
NCT04445090 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of BI 201335 NA in Healthy Male Subjects
NCT02182297 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Food Influences the Amount of BI 1323495 in the Blood of Healthy Men
NCT03802331 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers
NCT02259972 ·Status: COMPLETED ·Phase: PHASE1